Close

Scynexis' (SCYX) Treatment of Invasive Aspergillus Infections Granted Orphan Drug Status by FDA

Go back to Scynexis' (SCYX) Treatment of Invasive Aspergillus Infections Granted Orphan Drug Status by FDA
SCYNEXIS (NASDAQ: SCYX) Delayed: 1.47 +0.05 (3.52%)
Previous Close $1.42    52 Week High $7.29 
Open $1.42    52 Week Low $1.74 
Day High $1.52    P/E N/A 
Day Low $1.42    EPS $0.00 
Volume 184,056